{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:44:47Z","timestamp":1791837887495,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100024151","name":"CropLife Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00204-025-04037-9","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T06:50:04Z","timestamp":1746859804000},"page":"2727-2758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A proposal of criteria to support the EU classification on endocrine disruption for the thyroid modality and their application to four data-rich case studies"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3358-6164","authenticated-orcid":false,"given":"Stephanie","family":"Melching-Kollmuss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-2985","authenticated-orcid":false,"given":"Ursula G.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6762-0810","authenticated-orcid":false,"given":"Stefan","family":"Stinchcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-4619","authenticated-orcid":false,"given":"Helen","family":"Tinwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"issue":"3","key":"4037_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730\u2013741. https:\/\/doi.org\/10.1002\/etc.34","journal-title":"Environ Toxicol Chem"},{"issue":"6","key":"4037_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10408444.2023.2236134","volume":"53","author":"JHE Arts","year":"2023","unstructured":"Arts JHE, Faulhammer F, Schneider S, Salverda JGW (2023) Investigations on learning and memory function in extended one-generation reproductive toxicity studies - when considered needed and based on what? Crit Rev Toxicol 53(6):372\u2013384. https:\/\/doi.org\/10.1080\/10408444.2023.2236134","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"4037_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0160-5402(87)90070-2","volume":"18","author":"CK Atterwill","year":"1987","unstructured":"Atterwill CK, Collins P, Brown CG, Harland RF (1987) The perchlorate discharge test for examining thyroid function in rats. J Pharmacol Methods 18(3):199\u2013203. https:\/\/doi.org\/10.1016\/0160-5402(87)90070-2","journal-title":"J Pharmacol Methods"},{"key":"4037_CR4","doi-asserted-by":"publisher","unstructured":"Bagga AD, Johnson BP, Zhang Q (2024) Spatially and blood flow-dependent tissue distribution of thyroid hormones by plasma thyroid hormone binding proteins. bioRxiv [Preprint]. 2024 Apr 15:2023.12.20.572629. https:\/\/doi.org\/10.1101\/2023.12.20.572629","DOI":"10.1101\/2023.12.20.572629"},{"key":"4037_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yrtph.2018.07.025","volume":"98","author":"R Bartsch","year":"2018","unstructured":"Bartsch R, Brinkmann B, Jahnke G, Laube B, Lohmann R, Michaelsen S, Neumann I, Greim H (2018) Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances. Regul Toxicol Pharmacol 98:199\u2013208. https:\/\/doi.org\/10.1016\/j.yrtph.2018.07.025","journal-title":"Regul Toxicol Pharmacol"},{"key":"4037_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105763","volume":"96","author":"A Baze","year":"2023","unstructured":"Baze A, Wiss L, Horbal L, Biemel K, Asselin L, Richert L (2023) Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures. Toxicol in Vitro 96:105763. https:\/\/doi.org\/10.1016\/j.tiv.2023.105763","journal-title":"Toxicol in Vitro"},{"issue":"1","key":"4037_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/thy.2013.0109","volume":"24","author":"AC Bianco","year":"2014","unstructured":"Bianco AC, Anderson G, Forrest D, Galton VA, Gereben B, Kim BW, Kopp PA, Liao XH, Obregon MJ, Peeters RP, Refetoff S, Sharlin DS, Simonides WS, Weiss RE, Williams GR, Williams GR, American Thyroid Association Task Force on Approaches and Strategies to Investigate Thyroid Hormone Economy and Action (2014) American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24(1):88\u2013168. https:\/\/doi.org\/10.1089\/thy.2013.0109","journal-title":"Thyroid"},{"key":"4037_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.104884","volume":"122","author":"W Bomann","year":"2021","unstructured":"Bomann W, Tinwell H, Jenkinson P, Kluxen FM (2021) Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5\u2019-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation. Regul Toxicol Pharmacol 122:104884. https:\/\/doi.org\/10.1016\/j.yrtph.2021.104884","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"4037_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/bdrb.10045","volume":"68","author":"NY Choksi","year":"2003","unstructured":"Choksi NY, Jahnke GD, St Hilaire C, Shelby M (2003) Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res B Dev Reprod Toxicol 68(6):479\u2013491. https:\/\/doi.org\/10.1002\/bdrb.10045","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"3","key":"4037_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.yrtph.2007.04.007","volume":"48","author":"G Coelho-Palermo Cunha","year":"2007","unstructured":"Coelho-Palermo Cunha G, van Ravenzwaay B (2007) Standardization of the perchlorate discharge assay for thyroid toxicity testing in rats. Regul Toxicol Pharmacol 48(3):270\u2013278. https:\/\/doi.org\/10.1016\/j.yrtph.2007.04.007","journal-title":"Regul Toxicol Pharmacol"},{"key":"4037_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.reprotox.2019.05.011","volume":"96","author":"B Collet","year":"2020","unstructured":"Collet B, Simon E, van der Linden S, El Abdellaoui N, Naderman M, Man HY, Middelhof I, van der Burg B, Besselink H, Brouwer A (2020) Evaluation of a panel of in vitro methods for assessing thyroid receptor b and transthyretin transporter disrupting activities. Reprod Toxicol 96:432\u2013444. https:\/\/doi.org\/10.1016\/j.reprotox.2019.05.011","journal-title":"Reprod Toxicol"},{"key":"4037_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/B978-0-12-801238-3.66101-9","volume-title":"Comprehensive toxicology","author":"RL Cooper","year":"2018","unstructured":"Cooper RL, Zorrilla LM (2018) The hypothalamic\u2013pituitary\u2013thyroid axis as a target for environmental chemicals. In: McQueen CA (ed) Comprehensive toxicology, vol 4, 3rd edn. Elsevier Ltd., Oxford, pp 230\u2013275","edition":"3"},{"issue":"4","key":"4037_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1939-1676.2003.tb02467.x","volume":"17","author":"S Daminet","year":"2003","unstructured":"Daminet S, Ferguson D (2003) Influence of drugs on thyroid function in dogs. J Vet Intern Med 17(4):463\u2013472. https:\/\/doi.org\/10.1111\/j.1939-1676.2003.tb02467.x","journal-title":"J Vet Intern Med"},{"issue":"10","key":"4037_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/10408440600975242","volume":"36","author":"VL Dellarco","year":"2006","unstructured":"Dellarco VL, McGregor D, Berry SC, Cohen SM, Boobis AR (2006) Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action. Crit Rev Toxicol 36(10):793\u2013801. https:\/\/doi.org\/10.1080\/10408440600975242","journal-title":"Crit Rev Toxicol"},{"key":"4037_CR15","unstructured":"ECHA RAC (2013) ECHA Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at EU level of Imazalil (ISO), EC number: 252\u2013615\u20130, CAS number: 35554\u201344\u20130. CLH-O-0000002720\u201308\u201303\/F; adopted 4 June 2013"},{"key":"4037_CR16","unstructured":"ECHA RAC (2014) ECHA Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at EU level of Fluopyram, EC Number: NA, CAS Number: 658066\u201335\u20134. CLH-O-0000001412\u201386\u201346\/F; adopted 4 December 2014"},{"key":"4037_CR17","unstructured":"ECHA RAC (2015a) ECHA Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at EU level of Penthiopyrad (ISO); (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide, EC Number: N.A., CAS Number: 183675\u201382\u20133. CLH-O-0000001412\u201386\u201378\/F; adopted 4 December 2015"},{"key":"4037_CR18","unstructured":"ECHA RAC (2015b) ECHA Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at EU level of Thiacloprid (ISO); {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiaz olidin-2-ylidene}cyanamide, EC Number: N\/A, CAS Number: 111988\u201349\u20139. CLH-O-0000001412\u201386\u201354\/F; adopted 12 March 2015"},{"key":"4037_CR19","unstructured":"ECHA RAC (2018) ECHA Committee for Risk Assessment. Opinion proposing harmonised classification and labelling at EU level of 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide; fluxapyroxad, EC Number: -, CAS Number: 907204\u201331\u20133. CLH-O-0000001412\u201386\u2013254\/F; adopted 30 November 2018"},{"key":"4037_CR20","unstructured":"ECHA (2024) European Chemicals Agency. Guidance on the application of the CLP criteria. Part 3: Health hazards. Version 5.0, ECHA-24-G-06-EN, November 2024"},{"key":"4037_CR21","doi-asserted-by":"publisher","unstructured":"ECHA\/EFSA (2018) European Chemicals Agency and European Food Safety Authority with the technical support of the Joint Research Centre. Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528\/2012 and (EC) No 1107\/2009 (Andersson N, Arena M, Auteri D, Barmaz S, Grignard E, Kienzler A, Lepper P, Lostia AM, Munn S, Parra Morte JM, Pelllizzato F, Tarazon J, Terron A, Van der Linden S). ECHA-18-G-01-EN; EFSA J 16:1661\u2013170. https:\/\/doi.org\/10.2903\/j.efsa.2018.5311","DOI":"10.2903\/j.efsa.2018.5311"},{"key":"4037_CR22","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee (2017) European Food Safety Authority Scientific Committee. Scientific opinion on the guidance on the use of the weight of evidence approach in scientific assessments (Hardy A, Benford D, Halldorsson T, Jeger MJ, Knutsen HK, More S, Naegeli H, Noteborn H, Ockleford C, Ricci A, Rychen G, Schlatter JR, Silano V, Solecki R, Turck D, Benfenati E, Chaudhry QM, Craig P, Frampton G, Greiner M, Hart A, Hogstrand C, Lambre C, Luttik R, Makowski D, Siani A, Wahlstroem H, Aguilera J, Dorne J-L, Fernandez Dumont A, Hempen M, Valtuena Martinez S, Martino L, Smeraldi C, Terron A, Georgiadis N, Younes M). EFSA J 15(8):4971","DOI":"10.2903\/j.efsa.2017.4971"},{"key":"4037_CR23","unstructured":"EFSA (2019) European Food Safety Authority. EFSA workshop on in vitro comparative metabolism studies in regulatory pesticide risk assessment. Event report. EFSA Supporting Publication 2019:EN-1618"},{"key":"4037_CR24","unstructured":"EFSA (2020) European Food Safety Authority. Technical report on the outcome of the pesticides peer review meeting on general recurring issues in mammalian toxicology. EFSA Supporting Publication 2020: EN-1837"},{"key":"4037_CR25","doi-asserted-by":"publisher","unstructured":"EFSA (2023) European Food Safety Authority. Peer review of the pesticide risk assessment of the active substance metribuzin (\u00c1lvarez F, Arena M, Auteri D, Leite SB, Binaglia M, Castoldi AF, Chiusolo A, Cioca A-A, Colagiorgi A, Colas M, Crivellente F, De Lentdecker C, De Magistris I, Egsmose M, Fait G, Ferilli F, Gouliarmou V, Halling K, Nogareda LH, Ippolito A, Istace F, Jarrah S, Kardassi D, Kienzler A, Lanzoni A, Lava R, Leuschner R, Linguidoca A, Louisse J, Lythgo C, Magrans O, Mangas I, Miron I, Molnar T, Padovani L, Padricello V, Panzarea M, Parra Morte JM, Rizzuto S, Romac A, Rortais A, Serfimova R, Sharp R, Szentes C, Terron A, Theobald A, Tiramani M, Vianello G, Villamar- Bouza, L). EFSA J 21(8):1\u201332. https:\/\/doi.org\/10.2903\/j.efsa.2023.8140","DOI":"10.2903\/j.efsa.2023.8140"},{"key":"4037_CR26","doi-asserted-by":"publisher","unstructured":"EFSA (2024a) European Food Safety Authority. Specific effects on the thyroid relevant for performing a dietary cumulative risk assessment of pesticide residues: 2024 update (Crivellente F, Hern\u00e1ndez-Jerez AF, Lanzoni A, Metruccio F, Mohimont L, Nikolopoulou, Castoldi AF). EFSA J 22(3):e8672. https:\/\/doi.org\/10.2903\/j.efsa.2024.8672","DOI":"10.2903\/j.efsa.2024.8672"},{"key":"4037_CR27","doi-asserted-by":"publisher","unstructured":"EFSA (2024b) European Food Safety Authority. Peer review of the pesticide risk assessment of the active substance pyrimethanil (\u00c1lvarez F, Arena M, Auteri D, Leite SB, Binaglia M, Castoldi AF, Chiusolo A, Colagiorgi A, Colas M, Crivellente F, De Lentdecker C, De Magistris I, Egsmose M, Fait G, Ferilli F, Santonja GG, Gouliarmou V, Halling K, Nogareda LH, Ippolito A, Istace F, Jarrah S, Kardassi D, Kienzler A, Lanzoni A, Lava R, Leuschner R, Linguadoca A, Louisse J, Lythgo C, Magrans O, Mangas I, Mavriou G, Mio\u010d A, Miron I, Molnar T, Padovani L, Padricello V, Panzarea M, Parra Morte JM, Rizzuto S, Romac A, Rortais A, Santos M, Serafimova R, Sharp R, Szentes C, Terron A, Theobald A, Tiramani M, Vianello G, Villamar-Bouza L). EFSA J 22(10):e8998 (editorial amendment on 7 March 2025). https:\/\/doi.org\/10.2903\/j.efsa.2024.8998","DOI":"10.2903\/j.efsa.2024.8998"},{"key":"4037_CR28","unstructured":"EFSA (2024c) European Food Safety Authority. Report of Pesticide Peer Review TC 120. Ethiprole. 22 November 2023 meeting minutes; pages 203\u2013207 in: https:\/\/www.efsa.europa.eu\/sites\/default\/files\/2023-12\/minutes-ppr-mammalian-toxicity.pdf. Accessed 12 Mar 2025"},{"issue":"1","key":"4037_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/10408444.2013.835786","volume":"44","author":"CR Elcombe","year":"2014","unstructured":"Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D, Cattley RC, Ferguson SS, Geter D, Goetz A, Goodman JI, Hester S, Jacobs A, Omiecinski CJ, Schoeny R, Xie W, Lake BG (2014) Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 44(1):64\u201382. https:\/\/doi.org\/10.3109\/10408444.2013.835786","journal-title":"Crit Rev Toxicol"},{"key":"4037_CR30","unstructured":"European Commission (2017) Commission Delegated Regulation (EU) 2017\/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528\/2012 of the European Parliament and Council. OJ EU L 60:1\u201312, 17 November 2017"},{"key":"4037_CR31","unstructured":"European Commission (2018a) Commission Regulation (EU) 2018\/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107\/2009 by setting out criteria for the determination of endocrine disrupting properties. OJ EU L 101:33\u201336, 20 April 2018"},{"key":"4037_CR32","unstructured":"European Commission (2018b) Commission Implementing Regulation (EU) 2018\/1659 of 7 November 2018 amending Implementing Regulation (EU) No 844\/2012 in view of the scientific criteria for the determination of endocrine disrupting properties introduced by Regulation (EU) 2018\/605. OJ L 278:3, 8 November 2018"},{"key":"4037_CR33","unstructured":"European Commission (2018c) Directorate-General for Health and Food Safety. Conclusion on endocrine disrupting properties according to the new scientific criteria in pending applications of new active substances under Regulation (EC) No 1107\/2009. SANTE\/E4\/LF\/gb(2018)6773056. Ref. Ares(2018)6328544. Brussels, 10 December 2018"},{"key":"4037_CR34","unstructured":"European Commission (2018d) Draft Renewal Assessment Report under Regulation (EC) 1107\/2009, Boscalid. List of endpoints (RMS: Slovakia, Co-RMS: France). November 2018; https:\/\/www.efsa.europa.eu\/en\/consultations\/call\/190125. Accessed 12 Mar 2025"},{"key":"4037_CR35","unstructured":"European Commission (2023) Commission Delegated Regulation (EU) 2023\/707 of 19.12.2022 amending Regulation (EC) No 1272\/2008 as regards hazard classes and criteria for the classification, labelling and packaging of substances and mixtures. OJ L 93:7, 31 March 2023"},{"key":"4037_CR36","unstructured":"European Parliament and Council (2005) Regulation (EC) No 396\/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91\/414\/EEC. OJ L 70:1, 16 March 2005, consolidated version of 11 May 2024"},{"key":"#cr-split#-4037_CR37.1","unstructured":"European Parliament and Council (2008) Regulation"},{"key":"#cr-split#-4037_CR37.2","unstructured":"(EC) No 1272\/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67\/548\/EEC and 1999\/45\/EC, and amending Regulation"},{"key":"#cr-split#-4037_CR37.3","unstructured":"(EC) No 1907\/2006. OJ L 353:1-1355, 31 December 2008"},{"key":"#cr-split#-4037_CR38.1","unstructured":"European Parliament and Council (2009) Regulation"},{"key":"#cr-split#-4037_CR38.2","unstructured":"(EC) No 1107\/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market. OJ L 309:1-50, 24 November 2009"},{"key":"4037_CR39","unstructured":"European Parliament and Council (2010) Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ EU L 276:33, 20 October 2010"},{"key":"4037_CR40","unstructured":"European Parliament and Council (2012) Regulation (EU) No 528\/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products. OJ L 167:1, 27 June 2012"},{"issue":"2","key":"4037_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/toxsci\/kfad040","volume":"193","author":"J Ford","year":"2023","unstructured":"Ford J, Riutta C, Kosian PA, O\u2019Shaughessy K, Gilbert M (2023) Reducing uncertainties in quantitative adverse outcome pathways by analysis of thyroid hormone in the neonatal rat brain. Toxicol Sci 193(2):192\u2013203. https:\/\/doi.org\/10.1093\/toxsci\/kfad040. https:\/\/doi.org\/10.1093\/toxsci\/kfad111","journal-title":"Toxicol Sci"},{"issue":"3","key":"4037_CR42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00204-020-02961-6","volume":"95","author":"JR Foster","year":"2021","unstructured":"Foster JR, Tinwell H, Melching-Kollmuss S (2021) A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer. Arch Toxicol 95(3):807\u2013836. https:\/\/doi.org\/10.1007\/s00204-020-02961-6","journal-title":"Arch Toxicol"},{"issue":"1","key":"4037_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/metabo14010061","volume":"14","author":"C Hindrichs","year":"2024","unstructured":"Hindrichs C, Walk T, Landsiedel R, Kamp H, Schneider S, Melching-Kollmuss S, Funk-Weyer D (2024) Thyroid hormone metabolites quantified in pup and adult rat cerebellum, cortex and whole-brain samples using an automated online SPE-LC-MS\/MS method. Metabolites 14(1):61. https:\/\/doi.org\/10.3390\/metabo14010061","journal-title":"Metabolites"},{"issue":"8","key":"4037_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/0192623320972009","volume":"48","author":"M Huisinga","year":"2020","unstructured":"Huisinga M, Bertrand L, Chamanza R, Damiani I, Engelhardt J, Francke S, Freyberger A, Harada T, Harleman J, Kaufmann W, Keane K, K\u00f6hrle J, Lenz B, Marty MS, Melching-Kollmuss S, Palazzi X, Pohlmeyer-Esch G, Popp A, Rosol TJ, Strauss V, Van den Brink-Knol H, Wood CE, Yoshida M (2020) Adversity considerations for thyroid follicular cell hypertrophy and hyperplasia in nonclinical toxicity studies: results from the 6th ESTP International Expert Workshop. Toxicol Pathol 48(8):920\u2013938. https:\/\/doi.org\/10.1177\/0192623320972009","journal-title":"Toxicol Pathol"},{"issue":"3","key":"4037_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1289\/ehp.6637","volume":"112","author":"GD Jahnke","year":"2004","unstructured":"Jahnke GD, Choksi NY, Moore JA, Shelby MD (2004) Thyroid toxicants: assessing reproductive health effects. Environ Health Perspect 112(3):363\u2013368. https:\/\/doi.org\/10.1289\/ehp.6637","journal-title":"Environ Health Perspect"},{"key":"4037_CR47","unstructured":"JRC (2023) Joint Research Centre. Validation of a battery of mechanistic methods relevant for the detection of chemicals that can disrupt the thyroid hormone system (Bernasconi C, Langezaal I, Bartnicka J, Asturiol D, Bowe G, Coecke S, Kienzler A, Liska R, Milcamps A, Munoz Pineiro A, Pistollato F, Whelan M). JRC Technical Report. JRC132532\/EUR 31456 EN, Publications Office of the European Union"},{"issue":"1","key":"4037_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2108262","volume":"40","author":"D Karwelat","year":"2023","unstructured":"Karwelat D, K\u00fchnlenz J, Steger-Hartmann T, Bars R, Tinwell H, Marx U, Bauer S, Born O, Raschke M (2023) A rodent thyroid-liver chip to capture thyroid toxicity on organ function level. Altex 40(1):83\u2013102. https:\/\/doi.org\/10.14573\/altex.2108262","journal-title":"Altex"},{"key":"4037_CR49","doi-asserted-by":"crossref","unstructured":"Kent L, Choudhury K, Kellum S, Melching-Kollmuss S, Schafer A, Parmentier C, Sopko X, Richert L, Tinwell H, Walter C, Wohlman I, Zhang F (2024) Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay. In: Poster 02\u201330 at the 58th Congress of the European Societies of Toxicology (EUROTOX 2024), 8\u201311 September 2024, Copenhagen, Denmark. Toxicol Letters 399S2:2116","DOI":"10.1016\/j.toxlet.2024.07.300"},{"issue":"6","key":"4037_CR50","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/etc.4125","volume":"37","author":"D Knapen","year":"2018","unstructured":"Knapen D, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O\u2019Brien JM, Pollesch N, Smith LC, Zhang X, Villeneuve DL (2018) Adverse outcome pathway networks I: Development and applications. Environ Toxicol Chem 37(6):1723\u20131733. https:\/\/doi.org\/10.1002\/etc.4125","journal-title":"Environ Toxicol Chem"},{"issue":"1","key":"4037_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/toxsci\/kfw022","volume":"151","author":"JA Leonard","year":"2016","unstructured":"Leonard JA, Tan YM, Gilbert M, Isaacs K, El-Masri H (2016) Estimating margin of exposure to thyroid peroxidase inhibitors using high-throughput in vitro data, high-throughput exposure modeling, and physiologically based pharmacokinetic\/pharmacodynamic modeling. Toxicol Sci 151(1):57\u201370. https:\/\/doi.org\/10.1093\/toxsci\/kfw022","journal-title":"Toxicol Sci"},{"issue":"1","key":"4037_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/01926230252824725","volume":"30","author":"RW Lewis","year":"2002","unstructured":"Lewis RW, Billington R, Debryune E, Gamer A, Lang B, Carpanini F (2002) Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol 30(1):66\u201374. https:\/\/doi.org\/10.1080\/01926230252824725","journal-title":"Toxicol Pathol"},{"issue":"4","key":"4037_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/10408444.2021.1910625","volume":"51","author":"S Marty","year":"2021","unstructured":"Marty S, Beekhuijzen M, Charlton A, Hallmark N, Hannas BR, Jacobi S, Melching-Kollmuss S, Sauer UG, Sheets LP, Strauss V, Urbisch D, Botham PA, van Ravenzwaay B (2021) Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny\u2014part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments? Crit Rev Toxicol 51(4):328\u2013358. https:\/\/doi.org\/10.1080\/10408444.2021.1910625","journal-title":"Crit Rev Toxicol"},{"issue":"7","key":"4037_CR54","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/10408444.2022.2130166","volume":"52","author":"S Marty","year":"2022","unstructured":"Marty S, Sauer UG, Charlton A, Ghaffari R, Guignard D, Hallmark N, Hannas BR, Jacobi S, Marxfeld H-A, Melching-Kollmuss S, Sheets LP, Urbisch D, Botham PA, van Ravenzwaay B (2022) Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny\u2014part III: how is substance-mediated thyroid hormone imbalance in pregnant\/lactating rats or their progeny related to neurodevelopmental effects? Crit Rev Toxicol 52(7):546\u2013617. https:\/\/doi.org\/10.1080\/10408444.2022.2130166","journal-title":"Crit Rev Toxicol"},{"key":"4037_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jat.2949","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C (2014a) New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis. J Appl Toxicol 34:1\u201318. https:\/\/doi.org\/10.1002\/jat.2949","journal-title":"J Appl Toxicol"},{"key":"4037_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jat.2984","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R (2014b) Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol 34:595\u2013606. https:\/\/doi.org\/10.1002\/jat.2984","journal-title":"J Appl Toxicol"},{"issue":"6","key":"4037_CR57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/10408444.2023.2231033","volume":"53","author":"S Melching-Kollmuss","year":"2023","unstructured":"Melching-Kollmuss S, Bothe K, Charlton A, Gangadharan B, Ghaffari R, Jacobi S, Marty S, Marxfeld HA, McInnes EF, Sauer UG, Sheets LP, Strupp C, Tinwell H, Wiemann C, Botham PA, van Ravenzwaay B (2023) Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS). Crit Rev Toxicol 53(6):339\u2013371. https:\/\/doi.org\/10.1080\/10408444.2023.2231033","journal-title":"Crit Rev Toxicol"},{"key":"4037_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105283","volume":"137","author":"K Minami","year":"2023","unstructured":"Minami K, Suto H, Sato A, Ogata K, Kosaka T, Hojo H, Takahashi N, Tomiyama N, Fukuda T, Iwashita K, Aoyama H, Yamada T (2023) Feasibility study for a downsized comparative thyroid assay with measurement of brain thyroid hormones and histopathology in rats: Case study with 6-propylthiouracil and sodium phenobarbital at high dose. Regul Toxicol Pharm 137:105283. https:\/\/doi.org\/10.1016\/j.yrtph.2022.105283","journal-title":"Regul Toxicol Pharm"},{"key":"4037_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2024.100168","volume":"6","author":"K Minami","year":"2024","unstructured":"Minami K, Sato A, Tomiyama N, Ogata K, Kosaka T, Hojo H, Takahashi N, Suto H, Aoyama H, Yamada T (2024) Prenatal test cohort of a modified rat comparative thyroid assay adding brain thyroid hormone measurements and histology but lowering group size appears able to detect disruption by sodium phenobarbital. Curr Res Toxicol 6:100168. https:\/\/doi.org\/10.1016\/j.crtox.2024.100168","journal-title":"Curr Res Toxicol"},{"issue":"9","key":"4037_CR60","doi-asserted-by":"publisher","first-page":"95001","DOI":"10.1289\/EHP5297","volume":"127","author":"PD Noyes","year":"2019","unstructured":"Noyes PD, Friedman KP, Browne P, Haselman JT, Gilbert ME, Hornung MW, Barone S Jr, Crofton KM, Laws SC, Stoker TE, Simmons SO, Tietge JE, Degitz SJ (2019) Evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches. Environ Health Perspect 127(9):95001. https:\/\/doi.org\/10.1289\/EHP5297","journal-title":"Environ Health Perspect"},{"key":"4037_CR62","unstructured":"OECD (2017) Organisation for Economic Cooperation and Development. Series on testing and assessment No. 184. Revised guidance document on developing and assessing adverse outcome pathways. ENV\/JM\/MONO(2013)6. OECD Publishing, Paris"},{"key":"4037_CR63","unstructured":"OECD (2018) Organisation for Economic Cooperation and Development. Series on testing and assessment. Revised Guidance Document No. 150 on standardised test guidelines for evaluating chemicals for endocrine disruption. OECD Publishing, Paris"},{"key":"4037_CR64","unstructured":"OECD (2024) Organisation for Economic Cooperation and Development. Collaborate adverse outcome pathway Wiki (AOP-Wiki). Joint effort between European Commission Joint Research Centre and United States Environmental Protection Agency; AOP-Wiki v2.7 released on 30 March 2024; https:\/\/aopwiki.org\/. Accessed 12 Mar 2025"},{"key":"4037_CR65","unstructured":"OECD (2025) Organisation for Economic Cooperation and Development. OECD Test Guidelines for Chemicals; https:\/\/www.oecd.org\/en\/topics\/sub-issues\/testing-of-chemicals\/test-guidelines.html. Accessed 12 Mar 2025"},{"issue":"3","key":"4037_CR67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.yrtph.2015.02.012","volume":"71","author":"S Papineni","year":"2015","unstructured":"Papineni S, Marty MS, Rasoulpour RJ, LeBaron MJ, Pottenger LH, Eisenbrandt DL (2015) Mode of action and human relevance of pronamide-induced rat thyroid tumors. Regul Toxicol Pharmacol 71(3):541\u2013551. https:\/\/doi.org\/10.1016\/j.yrtph.2015.02.012","journal-title":"Regul Toxicol Pharmacol"},{"key":"4037_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115831","volume":"435","author":"C Parmentier","year":"2022","unstructured":"Parmentier C, Baze A, Untrau M, Kampkoetter A, Lasserre D, Richert L (2022) Evaluation of human relevance of Nicofluprole-induced rat thyroid disruption. Toxicol Appl Pharmacol 435:115831. https:\/\/doi.org\/10.1016\/j.taap.2021.115831","journal-title":"Toxicol Appl Pharmacol"},{"key":"4037_CR70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.toxrep.2020.12.019","volume":"8","author":"S Plummer","year":"2020","unstructured":"Plummer S, Beaumont B, Elcombe M, Wallace S, Wright J, Mcinnes EF, Currie RA, Cowie D (2020) Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues. Toxicol Rep 8:155\u2013161. https:\/\/doi.org\/10.1016\/j.toxrep.2020.12.019","journal-title":"Toxicol Rep"},{"issue":"9","key":"4037_CR73","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/10408444.2020.1839380","volume":"50","author":"UG Sauer","year":"2020","unstructured":"Sauer UG, Asiimwe A, Botham PA, Charlton A, Hallmark N, Jacobi S, Marty S, Melching-Kollmuss S, Palha JA, Strauss V, van Ravenzwaay B, Swaen G (2020) Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny\u2014part I: which parameters from human studies are most relevant for toxicological assessments? Crit Rev Toxicol 50(9):740\u2013763. https:\/\/doi.org\/10.1080\/10408444.2020.1839380","journal-title":"Crit Rev Toxicol"},{"key":"4037_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104736","volume":"117","author":"C Strupp","year":"2020","unstructured":"Strupp C, Quesnot N, Weber-Parmentier C, Richert L, Bomann WH, Singh P (2020) Weight of evidence and human relevance evaluation of the Benfluralin mode of action in rats (Part II): thyroid carcinogenesis. Regul Toxicol Pharmacol 117:104736. https:\/\/doi.org\/10.1016\/j.yrtph.2020.104736","journal-title":"Regul Toxicol Pharmacol"},{"issue":"11","key":"4037_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2131\/jts.49.509","volume":"49","author":"H Suto","year":"2024","unstructured":"Suto H, Ogata K, Minami K, Sato A, Tomiyama N, Kosaka T, Hojo H, Takahashi N, Aoyama H, Yamada T (2024) Perinatal maternal exposure to high-dose sodium phenobarbital in the modified Comparative Thyroid Assay: no significant reduction in thyroid hormones in pups despite notable effects in dams. J Toxicol Sci 49(11):509\u2013529. https:\/\/doi.org\/10.2131\/jts.49.509","journal-title":"J Toxicol Sci"},{"key":"4037_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105154","volume":"131","author":"H Tinwell","year":"2022","unstructured":"Tinwell H, Bars R (2022) Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat. Regul Toxicol Pharmacol 131:105154. https:\/\/doi.org\/10.1016\/j.yrtph.2022.105154","journal-title":"Regul Toxicol Pharmacol"},{"key":"4037_CR77","unstructured":"US EPA (2005) US Environmental Protection Agency. Guidance for thyroid assays in pregnant animals, fetuses and postnatal animals, and adult animals. US EPA, Office of Pesticide Programs, Health Effects Division, Washington, DC. 12 pp. https:\/\/www.epa.gov\/pesticide-registration\/guidance-thyroid-assays-pregnant-animals-fetuses-and-postnatal-animals-and. Accessed 12 Mar 2025"},{"key":"4037_CR78","unstructured":"US EPA (2024) US Environmental Protection Agency. Final test guidelines for pesticides and toxic substances; https:\/\/www.epa.gov\/test-guidelines-pesticides-and-toxic-substances\/final-test-guidelines-pesticides-and-toxic. Accessed 12 Mar 2025"},{"issue":"6","key":"4037_CR79","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/etc.4124","volume":"37","author":"DL Villeneuve","year":"2018","unstructured":"Villeneuve DL, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O\u2019Brien JM, Pollesch NL, Smith LC, Zhang X, Knapen D (2018) Adverse outcome pathway networks II: network analytics. Environ Toxicol Chem 37(6):1734\u20131748. https:\/\/doi.org\/10.1002\/etc.4124","journal-title":"Environ Toxicol Chem"},{"issue":"11","key":"4037_CR80","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00204-017-2020-z","volume":"91","author":"M Vinken","year":"2017","unstructured":"Vinken M, Knapen D, Vergauwen L, Hengstler JG, Angrish M, Whelan M (2017) Adverse outcome pathways: a concise introduction for toxicologists. Arch Toxicol 91(11):3697\u20133707. https:\/\/doi.org\/10.1007\/s00204-017-2020-z","journal-title":"Arch Toxicol"},{"issue":"7\u20138","key":"4037_CR82","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ansa.202200067","volume":"4","author":"AB Westbye","year":"2023","unstructured":"Westbye AB, Aas FE, Kelp O, Dahll LK, Thorsby PM (2023) Analysis of free, unbound thyroid hormones by liquid chromatography-tandem mass spectrometry: a mini-review of the medical rationale and analytical methods. Anal Sci Adv 4(7\u20138):244\u2013254. https:\/\/doi.org\/10.1002\/ansa.202200067","journal-title":"Anal Sci Adv"},{"key":"4037_CR83","unstructured":"WHO\/IPCS (2009) World Health Organisation\/International Programme on Chemical Safety. Principles and methods for the risk assessment of chemicals in food. Environmental Health Criteria 240, Annex I\u2014glossary of terms, World Health Organisation, Geneva, https:\/\/iris.who.int\/handle\/10665\/44065. Accessed 12 Mar 2025"},{"issue":"6","key":"4037_CR84","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/jat.4427","volume":"43","author":"C Wiemann","year":"2023","unstructured":"Wiemann C, Melching-Kollmuss S, Hambruch N, Wiss L, Stauber F, Richert L (2023) Boscalid shows increased thyroxin-glucuronidation in rat, but not in human hepatocytes In vitro. J Appl Toxicol 43(6):828\u2013844. https:\/\/doi.org\/10.1002\/jat.4427","journal-title":"J Appl Toxicol"},{"issue":"2","key":"4037_CR85","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2131\/jts.38.291","volume":"38","author":"T Yamada","year":"2013","unstructured":"Yamada T, Hasegawa R, Nishikawa S, Sakuratani Y, Yamada J, Yamashita T, Yoshinari K, Yamazoe Y, Kamata E, Ono A, Hirose A, Hayashi M (2013) New parameter that supports speculation on the possible mechanism of hypothyroidism induced by chemical substances in repeated-dose toxicity studies. J Toxicol Sci 38(2):291\u2013299. https:\/\/doi.org\/10.2131\/jts.38.291","journal-title":"J Toxicol Sci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04037-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T13:52:27Z","timestamp":1750859547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04037-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4037"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04037-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Administrative support, article publishing charges and the fees for writing assistance were provided by CropLife Europe. The employment affiliation of the authors is listed on the cover page. Authors\u2019 affiliations do not imply competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}